VREOD — Vireo Growth Inc.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1771706 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
2026-08-12
No quarterly fundamentals indexed for this ticker.
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.01T | $1133.00 | — |
| JNJ | JOHNSON & JOHNSON | $579.83B | $240.87 | — |
| ABBV | AbbVie Inc. | $402.35B | $227.73 | — |
| MRK | Merck & Co., Inc. | $294.03B | $119.05 | — |
| NVS | NOVARTIS AG | $292.07B | $153.07 | — |
News headlines (Yahoo Finance, 1h cache)
D.A. Davidson Acts as Exclusive Advisor to Bridgewell Agribusiness in Sale to Vireo Growth
2026-06-09 23:05 · Yahoo
Vireo Growth Inc. Appoints BDO as its New Auditor
2026-06-09 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.